SEZ

Radiological Software Device To Predict Future Breast Cancer Risk

Product code
SEZ
Device name
Radiological Software Device To Predict Future Breast Cancer Risk
Device class
Class 2
21 CFR
21 CFR 892.8500
Medical specialty
Radiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A radiological software device to predict future breast cancer risk is a device that analyzes radiological images generated by breast imaging modalities and/or inputs derived from radiological images to provide qualified healthcare professionals with a prediction of the risk of future (incident) breast cancer. This device produces a numeric probability and/or risk category indicative of the patient’s future breast cancer risk from the time the analyzed images were acquired. This device is not intended to diagnose, detect, or inform the treatment of cancer. The output of this device is not intended to guide interpretation of imaging exams.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-05-30.

NumberDecision dateApplicantDevice nameSummary
DEN2400472025-05-30Clairity, Inc.Allix5
Official FDA classification page: SEZ
Classification and pathway per current FDA publications. Data from openFDA (CC0).